Annotation Detail for AHSG
Basic Information Top
| Gene Symbol: | AHSG ( A2HS,AHS,FETUA,HSGA ) |
|---|---|
| Gene Full Name: | alpha-2-HS-glycoprotein |
| Band: | 3q27.3 |
| Quick Links | Entrez ID:197; OMIM: 138680; Uniprot ID:FETUA_HUMAN; ENSEMBL ID: ENSG00000145192; HGNC ID: 349 |
| Relate to Another Database: | SFARIGene; denovo-db |
| Location(AA) | Modification | |
|---|---|---|
| 134 | Phosphoserine. | |
| 138 | Phosphoserine. | |
| 156 | N-linked (GlcNAc...) (complex). | |
| 176 | N-linked (GlcNAc...) (complex). | |
| 256 | O-linked (GalNAc...). | |
| 270 | O-linked (GalNAc...). | |
| 325 | Phosphoserine (By similarity). | |
| 328 | Phosphoserine. | |
| 330 | Phosphoserine. | |
| 334 | Phosphoserine. | |
| 346 | O-linked (GalNAc...). | |
| Location(AA) | Modifications | Resource |
|---|---|---|
| 138 | Phosphoserine. | Swiss-Prot 53.0 |
| 156 | N-linked (GlcNAc...)./FTId=CAR | |
| 176 | N-linked (GlcNAc...)./FTId=CAR | |
| 256 | O-linked (GalNAc...)./FTId=CAR | |
| 270 | O-linked (GalNAc...)./FTId=CAR | |
| 325 | Phosphoserine (By similarity). | Swiss-Prot 53.0 |
| 328 | Phosphoserine (By similarity). | Swiss-Prot 53.0 |
| 330 | Phosphoserine. | Swiss-Prot 53.0 |
| 346 | O-linked (GalNAc...)./FTId=CAR |
| Location(AA) | Modification | Resource |
|---|---|---|
| 9 | S-palmitoyl | HMM predict |
| 134 | Phosphoserine(IKK) | HMM predict |
| 134 | Phosphoserine(CK1) | HMM predict |
| 138 | Phosphoserine | HMM predict |
| 156 | N-linked | HMM predict |
| 176 | N-linked | HMM predict |
| 179 | N-linked | HMM predict |
| 198 | Phosphotyrosine(EGFR) | HMM predict |
| 248 | O-linked | HMM predict |
| 257 | O-linked | HMM predict |
| 257 | Phosphoserine(ATM) | HMM predict |
| 280 | Phosphoserine(MAPK) | HMM predict |
| 280 | O-linked | HMM predict |
| 293 | O-linked | HMM predict |
| 328 | Phosphoserine(CDC2) | HMM predict |
| 361 | Arginine | HMM predict |
| 363 | Arginine | HMM predict |
- RefSeq ID: NM_001622
- Location:chr3 187813580-187821798
- strand:+
| Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
|---|---|---|---|---|---|---|
| CTCF | G2 | GSE9613 | 187800262 | 187800436 | 174 | 13232 |
| CTCF | G2 | GSE9613 | 187809305 | 187809609 | 304 | 4124 |
| CTCF | G2 | GSE9613 | 187810080 | 187810474 | 394 | 3304 |
| H3ac | HepG2 | E | 187802712 | 187803059 | 347 | 10695 |
| hScc1 | Bcell | GSE12603 | 187810080 | 187810259 | 179 | 3411 |
| hScc1 | G2 | GSE9613 | 187810080 | 187810819 | 739 | 3131 |
| Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
|---|---|---|---|---|---|---|
| CTCF | G2 | GSE9613 | 187826911 | 187827097 | 186 | 5206 |
| CTCF | G2 | GSE9613 | 187827523 | 187827783 | 260 | 5855 |
| Transcrip Factors | Experimental Cell | Database | TF Binding Start | TF Binding End | TF Binding Length | The Distance to Gene |
|---|---|---|---|---|---|---|
| CTCF | G2 | GSE9613 | 187813949 | 187814478 | 529 | 0 |
| CTCF | G2 | GSE9613 | 187815025 | 187816371 | 1346 | 0 |
| CTCF | G2 | GSE9613 | 187817464 | 187818214 | 750 | 0 |
| CTCF | G2 | GSE9613 | 187821190 | 187821325 | 135 | 0 |
| H3ac | HepG2 | E | 187812651 | 187816371 | 3720 | 0 |
| H3ac | HepG2 | E | 187817464 | 187817601 | 137 | 0 |
| P300 | T0-glioblastoma | GSE21026 | 187817143 | 187817962 | 819 | 0 |
| P300 | T30-glioblastoma | GSE21026 | 187817173 | 187818165 | 992 | 0 |
| TFAP2C | MCF7 | GSE21234 | 187817289 | 187817905 | 616 | 0 |
| hScc1 | Bcell | GSE12603 | 187815320 | 187816371 | 1051 | 0 |
| hScc1 | Bcell | GSE12603 | 187817464 | 187818249 | 785 | 0 |
| hScc1 | CdLS | GSE12603 | 187815219 | 187815846 | 627 | 0 |
| hScc1 | CdLS | GSE12603 | 187817464 | 187818175 | 711 | 0 |
| hScc1 | G2 | GSE9613 | 187815254 | 187815846 | 592 | 0 |
| hScc1 | G2 | GSE9613 | 187817499 | 187818139 | 640 | 0 |
Validated miRNA targets